NRBO - Neurobo Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $10717.89. This is a potential upside of $10716 (566984.13%) from yesterday's end of day stock price of $1.89.

Neurobo Pharmaceuticals's activity chart (see below) currently has 13 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 52% with an average time for these price targets to be met of 96 days.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 31-Jan-2021. First documented stock forecast 29-Aug-2016.

Best performing analysts who are covering NRBO - Neurobo Pharmaceuticals:

Matthew Andrews Yasmeen Rahimi John Newman Francois Brisebois Raghuram Selvaraju

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$4800

4 years 8 months 16 days ago
(31-Jan-2021)

0/1 (0%)

$2520 (110.53%)

Hold

$12000

$11998.11 (634820.62%)

$108000

7 years 2 months 4 days ago
(12-Aug-2018)

3/5 (60%)

$2040 (20.48%)

130

Hold

$12000

$11998.11 (634820.62%)

7 years 2 months 7 days ago
(09-Aug-2018)

1/1 (100%)

$1200 (11.11%)

27

$12000

$11998.11 (634820.62%)

7 years 2 months 8 days ago
(08-Aug-2018)

1/2 (50%)

$-7620 (-38.84%)

1

Buy

8 years 27 days ago
(19-Sep-2017)

1/2 (50%)

$55440 (72.41%)

322

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NRBO (Neurobo Pharmaceuticals) average time for price targets to be met?

On average it took 96 days on average for the stock forecasts to be realized with a an average price target met ratio 52

Which analyst has the current highest performing score on NRBO (Neurobo Pharmaceuticals) with a proven track record?

MATTHEW ANDREWS

Which analyst has the current lower performing score on NRBO (Neurobo Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on NRBO (Neurobo Pharmaceuticals)?

Matthew Andrews has 7 price targets and 9 ratings on NRBO

Which analyst is the currently most bullish on NRBO (Neurobo Pharmaceuticals)?

Francois Brisebois with highest potential upside - $11998.11

Which analyst is the currently most reserved on NRBO (Neurobo Pharmaceuticals)?

John Newman with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?